The claudin–transcription factor signaling pathway

References

• Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and −2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol. 1998;141(7):1–11. doi:https://doi.org/10.1083/jcb.141.7.1539.
   PubMed Web of Science ®Google Scholar
• Furuse M, Sasaki H, Fujimoto K, Tsukita S. A single gene product, claudin-1 or −2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J Cell Biol. 1998;143(2):391–401. doi:https://doi.org/10.1083/jcb.143.2.391.
   PubMed Web of Science ®Google Scholar
• Furuse M, Tsukita S. Claudins in occluding junctions of humans and flies. Trends Cell Biol. 2006;16(4):181–188. doi:https://doi.org/10.1016/j.tcb.2006.02.006.
   PubMed Web of Science ®Google Scholar
• Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Annu Rev Physiol. 2006;68(1):403–429. doi:https://doi.org/10.1146/annurev.physiol.68.040104.131404.
   PubMedGoogle Scholar
• Chiba H, Osanai M, Murata M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta. 2008;1778(3):588–600. doi:https://doi.org/10.1016/j.bbamem.2007.08.017.
   PubMed Web of Science ®Google Scholar
• Zihni C, Mills C, Matter K, Balda MS. Tight junctions: from simple barriers to multifunctional molecular gates. Nat Rev Mol Cell Biol. 2016;17(9):564–580. doi:https://doi.org/10.1038/nrm.2016.80.
   PubMed Web of Science ®Google Scholar
• Tsukita S, Tanaka H, Tamura TA. The claudins: from tight junctions to biological systems. Trends Biochem Sci. 2019;44(2):141–152. doi:https://doi.org/10.1016/j.tibs.2018.09.008.
   PubMed Web of Science ®Google Scholar
• Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta. 2008;1778(3):631–645. doi:https://doi.org/10.1016/j.bbamem.2007.10.018.
   PubMed Web of Science ®Google Scholar
• Piontek J, Winkler L, Wolburg H, Müller SL, Zuleger N, Piehl C, Wiesner B, Krause G, Blasig IE. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008;22(1):146–158. doi:https://doi.org/10.1096/fj.07-8319com.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Nishizawa T, Tani K, Yamazaki Y, Tamura A, Ishitani R, Dohmae N, Tsukita S, Nureki O, Fujiyoshi Y. Crystal structure of a claudin provides insight into the architecture of tight junctions. Science. 2014;344(6181):304–307. doi:https://doi.org/10.1126/science.1248571.
   PubMed Web of Science ®Google Scholar
• Haseloff RF, Piontek J, Blasig IE. Chapter 5 – the investigation of cis- and trans-interactions between claudins. In: Yu AS L editor. Current topics in membranes. Academic Press, USA; 2010. p. 97–112.
   Google Scholar
• Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol. 1999;147(6):1351–1363. doi:https://doi.org/10.1083/jcb.147.6.1351.
   PubMed Web of Science ®Google Scholar
• Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol. 2001;2(4):285–293. doi:https://doi.org/10.1038/35067088.
   PubMed Web of Science ®Google Scholar
• González-Mariscal L, Garay E, Quirós M. Chapter 6 – regulation of claudins by posttranslational modifications and cell-signaling cascades. In: Yu AS L editor. Current topics in membranes. Academic Press, USA; 2010. p. 113–150.
   Google Scholar
• Van Itallie CM, Anderson JM. Phosphorylation of tight junction transmembrane proteins: many sites, much to do. Tissue Barriers. 2018;6(1):e1382671. doi:https://doi.org/10.1080/21688370.2017.1382671.
   PubMed Web of Science ®Google Scholar
• Tabariès S, McNulty A, Ouellet V, Annis MG, Dessureault M, Vinette M, Hachem Y, Lavoie B, Omeroglu A, Simon H-G, et al. Afadin cooperates with claudin-2 to promote breast cancer metastasis. Genes Dev. 2019;33(3–4):180–193. doi:https://doi.org/10.1101/gad.319194.118.
   PubMed Web of Science ®Google Scholar
• Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol. 2011;12(3):189–197. doi:https://doi.org/10.1038/nrm3068.
   PubMed Web of Science ®Google Scholar
• Günzel D, Yu ASL. Claudins and the modulation of tight junction permeability. Physiol Rev. 2013;93(2):525–569. doi:https://doi.org/10.1152/physrev.00019.2012.
   PubMed Web of Science ®Google Scholar
• Sawada N. Tight junction-related human diseases. Pathol Int. 2013;63(1):1–12. doi:https://doi.org/10.1111/pin.12021.
   PubMed Web of Science ®Google Scholar
• Barmeyer C, Schulzke JD, Fromm M. Claudin-related intestinal diseases. Semin Cell Dev Biol. 2015;42:30–38. doi:https://doi.org/10.1016/j.semcdb.2015.05.006.
   PubMed Web of Science ®Google Scholar
• Tawar RG, Colpitts CC, Lupberger J, El-Saghire H, Zeisel MB, Baumert TF. Claudins and pathogenesis of viral infection. Semin Cell Dev Biol. 2015;42:39–46. doi:https://doi.org/10.1016/j.semcdb.2015.04.011.
   PubMed Web of Science ®Google Scholar
• Zeisel MB, Dhawan P, Baumert TF. Tight junction proteins in gastrointestinal and liver disease. Gut. 2019;68(3):547–561. doi:https://doi.org/10.1136/gutjnl-2018-316906.
   PubMed Web of Science ®Google Scholar
• Culemann S, Grüneboom A, Nicolás-Ávila JÁ, Weidner D, Lämmle KF, Rothe T, Quintana JA, Kirchner P, Krljanac B, Eberhardt M, et al. Locally renewing resident synovial macrophages provide a protective barrier for the joint. Nature. 2019;572(7771):670–675. doi:https://doi.org/10.1038/s41586-019-1471-1.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Yu J, Lin W, Tang H, Zhang W, Lu B. Molecular hydrogen accelerates the reversal of acute obstructive cholangitis‑induced liver dysfunction by restoring gap and tight junctions. Mol Med Rep. 2019;19(6):5177–5184. doi:https://doi.org/10.3892/mmr.2019.10179.
   PubMed Web of Science ®Google Scholar
• Zuo L, Kuo W-T, Turner JR. Tight junctions as targets and effectors of mucosal immune homeostasis. Cell Mol Gastroenterol Hepatol. 2020;10(2):327–340. doi:https://doi.org/10.1016/j.jcmgh.2020.04.001.
   PubMed Web of Science ®Google Scholar
• Oliveira SS, Morgado-Díaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell Mol Life Sci. 2007;64(1):17–28. doi:https://doi.org/10.1007/s00018-006-6314-1.
   PubMed Web of Science ®Google Scholar
• Valle BL, Morin PJ. Chapter 13 – claudins in cancer biology. In: Yu AS L editor. Current topics in membranes. Academic Press, United States; 2010. p. 293–333.
   Google Scholar
• Turksen K, Troy T-C. Junctions gone bad: claudins and loss of the barrier in cancer. Biochim Biophys Acta. 2011;1816(1):73–79. doi:https://doi.org/10.1016/j.bbcan.2011.04.001.
   PubMed Web of Science ®Google Scholar
• Osanai M, Takasawa A, Murata M, Sawada N. Claudins in cancer: bench to bedside. Pflugers Arch. 2017;469(1):55–67. doi:https://doi.org/10.1007/s00424-016-1877-7.
   PubMed Web of Science ®Google Scholar
• Tabariès S, Siegel PM. The role of claudins in cancer metastasis. Oncogene. 2017;36(9):1176–1190. doi:https://doi.org/10.1038/onc.2016.289.
   PubMed Web of Science ®Google Scholar
• Gowrikumar S, Singh AB, Dhawan P. Role of claudin proteins in regulating cancer stem cells and chemoresistance-potential implication in disease prognosis and therapy. Int J Mol Sci. 2019;21(1):53. doi:https://doi.org/10.3390/ijms21010053.
   Web of Science ®Google Scholar
• Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Macha MA, Yadav SK, Krishnankutty R, Muralitharan S, Al-Naemi H, et al. Claudin-1, a double-edged sword in cancer. Int J Mol Sci. 2020;21(2):569. Available from: http://dx.doi.org/10.3390/ijms21020569.
   Web of Science ®Google Scholar
• Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, Takahashi A, Flanigan ME, Aleyasin H, LeClair KB, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20(12):1752–1760. doi:https://doi.org/10.1038/s41593-017-0010-3.
   PubMed Web of Science ®Google Scholar
• Nishiura K, Ichikawa-Tomikawa N, Sugimoto K, Kunii Y, Kashiwagi K, Tanaka M, Yokoyama Y, Hino M, Sugino T, Yabe H, et al. PKA activation and endothelial claudin-5 breakdown in the schizophrenic prefrontal cortex. Oncotarget. 2017;8(55):93382–93391. doi:https://doi.org/10.18632/oncotarget.21850.
   PubMedGoogle Scholar
• Greene C, Campbell M. Tight junction modulation of the blood brain barrier: CNS delivery of small molecules. Tissue Barriers. 2016;4(1):e1138017. doi:https://doi.org/10.1080/21688370.2015.1138017.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Shinohara M, Shinohara M, Yamazaki A, Murray ME, Liesinger AM, Heckman MG, Lesser ER, Parisi JE, Petersen RC, et al. Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression. Brain. 2019;142(4):1077–1092. doi:https://doi.org/10.1093/brain/awz011.
   PubMedGoogle Scholar
• Niu J, Tsai H-H, Hoi KK, Huang N, Yu G, Kim K, Baranzini SE, Xiao L, Chan JR, Fancy SPJ. Aberrant oligodendroglial-vascular interactions disrupt the blood-brain barrier, triggering CNS inflammation. Nat Neurosci. 2019;22(5):709–718. doi:https://doi.org/10.1038/s41593-019-0369-4.
   PubMed Web of Science ®Google Scholar
• Dudek KA, Dion-Albert L, Lebel M, LeClair K, Labrecque S, Tuck E, Ferrer Perez C, Golden SA, Tamminga C, Turecki G, et al. Molecular adaptations of the blood-brain barrier promote stress resilience vs. Depression Proc Natl Acad Sci U S A. 2020;117(6):3326–3336. doi:https://doi.org/10.1073/pnas.1914655117.
   PubMed Web of Science ®Google Scholar
• Greene C, Hanley N, Campbell M. Blood-brain barrier associated tight junction disruption is a hallmark feature of major psychiatric disorders. Transl Psychiatry. 2020;10(1):373. doi:https://doi.org/10.1038/s41398-020-01054-3.
   PubMed Web of Science ®Google Scholar
• Greene C, Hanley N, Campbell M. Claudin-5: gatekeeper of neurological function. Fluids Barriers CNS. 2019;16(1):3. doi:https://doi.org/10.1186/s12987-019-0123-z.
   PubMed Web of Science ®Google Scholar
• Chiba H, Ichikawa-Tomikawa N, Imura T, Sugimoto K. The region-selective regulation of endothelial claudin-5 expression and signaling in brain health and disorders. J Cell Physiol. 2021. Available from https://doi.org/10.1002/jcp.30357
   Google Scholar
• Spadaro D, Le S, Laroche T, Mean I, Jond L, Yan J, Citi S. Tension-dependent stretching activates ZO-1 to control the junctional localization of its interactors. Curr Biol. 2017;27(3783–3795.e8):3783–3795.e8. doi:https://doi.org/10.1016/j.cub.2017.11.014.
   PubMedGoogle Scholar
• Zenker J, White MD, Gasnier M, Alvarez YD, Lim HYG, Bissiere S, Biro M, Plachta N. Expanding actin rings zipper the mouse embryo for blastocyst formation. Cell. 2018;173(3):776–791.e17. doi:https://doi.org/10.1016/j.cell.2018.02.035.
   PubMed Web of Science ®Google Scholar
• Bendriem RM, Singh S, Aleem AA, Antonetti DA, Ross ME. Tight junction protein occludin regulates progenitor self-renewal and survival in developing cortex. Elife. 2019;8:664. doi:https://doi.org/10.7554/eLife.49376.
   Web of Science ®Google Scholar
• Beutel O, Maraspini R, Pombo-García K, Martin-Lemaitre C, Honigmann A. Phase separation of zonula occludens proteins drives formation of tight junctions. Cell. 2019;179(4):923–936.e11. doi:https://doi.org/10.1016/j.cell.2019.10.011.
   PubMed Web of Science ®Google Scholar
• Kuo W-T, Shen L, Zuo L, Shashikanth N, Ong MLDM, Wu L, Zha J, Edelblum KL, Wang Y, Wang Y, et al. Inflammation-induced occludin downregulation limits epithelial apoptosis by suppressing caspase-3 expression. Gastroenterology. 2019;157(5):1323–1337. doi:https://doi.org/10.1053/j.gastro.2019.07.058.
   PubMed Web of Science ®Google Scholar
• Otani T, Nguyen TP, Tokuda S, Sugihara K, Sugawara T, Furuse K, Miura T, Ebnet K, Furuse FM. Claudins and JAM-A coordinately regulate tight junction formation and epithelial polarity. J Cell Biol. 2019;218(10):3372–3396. doi:https://doi.org/10.1083/jcb.201812157.
   PubMed Web of Science ®Google Scholar
• Schwayer C, Shamipour S, Pranjic-Ferscha K, Schauer A, Balda M, Tada M, Matter K, Heisenberg C-P. Mechanosensation of tight junctions depends on ZO-1 phase separation and flow. Cell. 2019;179(4):937–952.e18. doi:https://doi.org/10.1016/j.cell.2019.10.006.
   PubMed Web of Science ®Google Scholar
• Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, Kassem R, Lenoir S, Agasse F, Braz BY, et al. Huntington’s disease alters human neurodevelopment. Science. 2020;369(6505):787–793. doi:https://doi.org/10.1126/science.aax3338.
   PubMed Web of Science ®Google Scholar
• Belardi B, Hamkins-Indik T, Harris AR, Kim J, Xu K, Fletcher DA, Weak A. Link with actin organizes tight junctions to control epithelial permeability. Dev Cell. 2020;54(792–804.e7):792–804.e7. doi:https://doi.org/10.1016/j.devcel.2020.07.022.
   PubMedGoogle Scholar
• Citi S. Cell Biology: Tight junctions as biomolecular condensates. Curr Biol. 2020;30(2):R83–6. doi:https://doi.org/10.1016/j.cub.2019.11.060.
   PubMed Web of Science ®Google Scholar
• Hartmann C, Schwietzer YA, Otani T, Furuse M, Ebnet K. Physiological functions of junctional adhesion molecules (JAMs) in tight junctions. Biochim Biophys Acta. 2020;1862(9):183299. doi:https://doi.org/10.1016/j.bbamem.2020.183299.
   Web of Science ®Google Scholar
• Lauko A, Mu Z, Gutmann DH, Naik UP, Lathia JD. Junctional adhesion molecules in cancer: a paradigm for the diverse functions of cell-cell interactions in tumor progression. Cancer Res. 2020;80(22):4878–4885. doi:https://doi.org/10.1158/0008-5472.CAN-20-1829.
   PubMed Web of Science ®Google Scholar
• Otani T, Furuse M. Tight junction structure and function revisited. Trends Cell Biol. 2020;30(10):805–817. doi:https://doi.org/10.1016/j.tcb.2020.08.004.
   PubMed Web of Science ®Google Scholar
• Zhou T, Lu Y, Xu C, Wang R, Zhang L, Lu P. Occludin protects secretory cells from ER stress by facilitating SNARE-dependent apical protein exocytosis. Proc Natl Acad Sci U S A. 2020;117(9):4758–4769. doi:https://doi.org/10.1073/pnas.1909731117.
   PubMed Web of Science ®Google Scholar
• Kubota H, Chiba H, Takakuwa Y, Osanai M, Tobioka H, Kohama G, Mori M, Retinoid SN. X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation. Exp Cell Res. 2001;263(1):163–172. doi:https://doi.org/10.1006/excr.2000.5113.
   PubMed Web of Science ®Google Scholar
• Chiba H, Gotoh T, Kojima T, Satohisa S, Kikuchi K, Osanai M, Sawada N. Hepatocyte nuclear factor (HNF)-4alpha triggers formation of functional tight junctions and establishment of polarized epithelial morphology in F9 embryonal carcinoma cells. Exp Cell Res. 2003;286(2):288–297. doi:https://doi.org/10.1016/S0014-4827(03)00116-2.
   PubMed Web of Science ®Google Scholar
• Satohisa S, Chiba H, Osanai M, Ohno S, Kojima T, Saito T, Sawada N. Behavior of tight-junction, adherens-junction and cell polarity proteins during HNF-4alpha-induced epithelial polarization. Exp Cell Res. 2005;310(1):66–78. doi:https://doi.org/10.1016/j.yexcr.2005.06.025.
   PubMed Web of Science ®Google Scholar
• Chiba H, Sakai N, Murata M, Osanai M, Ninomiya T, Kojima T, Sawada N. The nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilli. J Cell Biol. 2006;175(6):971–980. doi:https://doi.org/10.1083/jcb.200608012.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ichikawa-Tomikawa N, Satohisa S, Akashi Y, Kanai R, Saito T, Sawada N, Chiba H. The tight-junction protein claudin-6 induces epithelial differentiation from mouse F9 and embryonic stem cells. PLoS One. 2013;8(10):e75106. doi:https://doi.org/10.1371/journal.pone.0075106.
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Ichikawa-Tomikawa N, Kashiwagi K, Endo C, Tanaka S, Sawada N, Watabe T, Higashi T, Chiba H. Cell adhesion signals regulate the nuclear receptor activity. Proc Natl Acad Sci U S A. 2019;116(49):24600–24609. doi:https://doi.org/10.1073/pnas.1913346116.
   PubMed Web of Science ®Google Scholar
• Li C-F, Chen J-Y, Ho Y-H, Hsu W-H, Wu L-C, Lan H-Y, Hsu D-S-S, Tai S-K, Chang Y-C, Yang M-H. Snail-induced claudin-11 prompts collective migration for tumour progression. Nat Cell Biol. 2019;21(2):251–262. doi:https://doi.org/10.1038/s41556-018-0268-z.
   PubMed Web of Science ®Google Scholar
• Singh AB, Sharma A, Dhawan P. Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner. Carcinogenesis. 2012;33(12):2538–2547. doi:https://doi.org/10.1093/carcin/bgs275.
   PubMed Web of Science ®Google Scholar
• Huang H, Li L, Wu C, Schibli D, Colwill K, Ma S, Li C, Roy P, Ho K, Songyang Z, et al. Defining the specificity space of the human SRC homology 2 domain. Mol Cell Proteomics. 2008;7(4):768–784. doi:https://doi.org/10.1074/mcp.M700312-MCP200.
   PubMed Web of Science ®Google Scholar
• Filippakopoulos P, Müller S, Knapp S. SH2 domains: modulators of nonreceptor tyrosine kinase activity. Curr Opin Struct Biol. 2009;19(6):643–649. doi:https://doi.org/10.1016/j.sbi.2009.10.001.
   PubMed Web of Science ®Google Scholar
• Liu BA, Engelmann BW, Jablonowski K, Higginbotham K, Stergachis AB, Nash PD. SRC homology 2 domain binding sites in insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome. Cell Commun Signal. 2012;10(1):27. doi:https://doi.org/10.1186/1478-811X-10-27.
   PubMedGoogle Scholar
• Mayer BJ. The discovery of modular binding domains: building blocks of cell signalling. Nat Rev Mol Cell Biol. 2015;16(11):691–698. doi:https://doi.org/10.1038/nrm4068.
   PubMed Web of Science ®Google Scholar
• Shimobaba S, Taga S, Akizuki R, Hichino A, Endo S, Matsunaga T, Watanabe R, Yamaguchi M, Yamazaki Y, Sugatani J, et al. Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells. Biochim Biophys Acta. 2016;1863(6):1170–1178. doi:https://doi.org/10.1016/j.bbamcr.2016.02.015.
   PubMed Web of Science ®Google Scholar
• Luo J, Chimge N-O, Zhou B, Flodby P, Castaldi A, Firth AL, Liu Y, Wang H, Yang C, Marconett CN, et al. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro. Int J Cancer. 2018;143(12):3169–3180. doi:https://doi.org/10.1002/ijc.31734.
   PubMed Web of Science ®Google Scholar
• Brunton VG, Irj M, Frame MC. Cell adhesion receptors, tyrosine kinases and actin modulators: a complex three-way circuitry. Biochim Biophys Acta. 2004;1692(2–3):121–144. doi:https://doi.org/10.1016/j.bbamcr.2004.04.010.
   PubMed Web of Science ®Google Scholar
• McLachlan RW, Kraemer A, Helwani FM, Kovacs EM, Yap AS, Mostov K. E-cadherin adhesion activates c-Src signaling at cell-cell contacts. Mol Biol Cell. 2007;18(8):3214–3223. doi:https://doi.org/10.1091/mbc.e06-12-1154.
   PubMed Web of Science ®Google Scholar
• Cabodi S, Di Stefano P, Leal M, Del Pc TA, Bisaro B, Morello V, Damiano L, Aramu S, Repetto D, Tornillo G, et al. Integrins and signal transduction. Adv Exp Med Biol. 2010;674:43–54.
   PubMed Web of Science ®Google Scholar
• Canel M, Serrels A, Frame MC, Brunton VG. E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci. 2013;126(2):393–401. doi:https://doi.org/10.1242/jcs.100115.
   PubMed Web of Science ®Google Scholar
• Xiao R, Xi X-D, Chen Z, Chen S-J S-J, Meng G. Structural framework of c-Src activation by integrin β3. Blood. 2013;121(4):700–706. doi:https://doi.org/10.1182/blood-2012-07-440644.
   PubMed Web of Science ®Google Scholar
• Ochs K, Málaga-Trillo E. Common themes in PrP signaling: the Src remains the same. Front Cell Dev Biol. 2014;2:63. doi:https://doi.org/10.3389/fcell.2014.00063.
   PubMed Web of Science ®Google Scholar
• Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533–548. doi:https://doi.org/10.1038/s41568-018-0038-z.
   PubMed Web of Science ®Google Scholar
• Witherden DA, Verdino P, Rieder SE, Garijo O, Mills RE, Teyton L, Fischer WH, Wilson IA, Havran WL. The junctional adhesion molecule JAML is a costimulatory receptor for epithelial gammadelta T cell activation. Science. 2010;329(5996):1205–1210. doi:https://doi.org/10.1126/science.1192698.
   PubMed Web of Science ®Google Scholar
• Yaffe MB. MAGUK SH3 domains–swapped and stranded by their kinases? Structure. 2002;10(1):3–5. doi:https://doi.org/10.1016/S0969-2126(01)00705-5.
   PubMed Web of Science ®Google Scholar
• Lim WA, Pawson T. Phosphotyrosine signaling: evolving a new cellular communication system. Cell. 2010;142(5):661–667. doi:https://doi.org/10.1016/j.cell.2010.08.023.
   PubMed Web of Science ®Google Scholar
• Liu BA, Nash PD. Evolution of SH2 domains and phosphotyrosine signalling networks. Philos Trans R Soc Lond B Biol Sci. 2012;367(1602):2556–2573. doi:https://doi.org/10.1098/rstb.2012.0107.
   PubMed Web of Science ®Google Scholar
• Wagner MJ, Stacey MM, Liu BA, Pawson T. Molecular mechanisms of SH2- and PTB-domain-containing proteins in receptor tyrosine kinase signaling. Cold Spring Harb Perspect Biol. 2013;5(12):a008987. doi:https://doi.org/10.1101/cshperspect.a008987.
   PubMed Web of Science ®Google Scholar
• Kojima M, Sugimoto K, Tanaka M, Endo Y, Kato H, Honda T, Furukawa S, Nishiyama H, Watanabe T, Soeda S, et al. Prognostic significance of aberrant claudin-6 expression in endometrial cancer. Cancers. 2020;12(10):2748. Available from: http://dx.doi.org/10.3390/cancers12102748.
   Web of Science ®Google Scholar
• Kojima M, Sugimoto K, Kobayashi M, Ichikawa-Tomikawa N, Kashiwagi K, Watanabe T, Soeda S, Fujimori K, Chiba H. Aberrant claudin-6-adhesion signaling promotes endometrial cancer progression via estrogen receptor α. Mol Cancer Res [ in press; Available from]. 2021. https://mcr.aacrjournals.org/content/early/2021/03/16/1541-7786.MCR-20-0835
   PubMed Web of Science ®Google Scholar
• Lang F, Böhmer C, Palmada M, Seebohm G, Strutz-Seebohm N, Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev. 2006;86(4):1151–1178. doi:https://doi.org/10.1152/physrev.00050.2005.
   PubMed Web of Science ®Google Scholar
• Hagen SJ, Ang L-H, Zheng Y, Karahan SN, Wu J, Wang YE, Caron TJ, Gad AP, Muthupalani S, Fox JG. Loss of tight junction protein claudin 18 promotes progressive neoplasia development in mouse stomach. Gastroenterology. 2018;155(6):1852–1867. doi:https://doi.org/10.1053/j.gastro.2018.08.041.
   PubMed Web of Science ®Google Scholar
• Zhou B, Flodby P, Luo J, Castillo DR, Liu Y, Yu F-X, McConnell A, Varghese B, Li G, Chimge N-O, et al. Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest. 2018;128(3):970–984. doi:https://doi.org/10.1172/JCI90429.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Sentani K, Tanaka H, Yano T, Suzuki K, Oshima M, Yasui W, Tamura A, Tsukita S. Deficiency of stomach-type claudin-18 in mice induces gastric tumor formation independent of H pylori infection. Cell Mol Gastroenterol Hepatol. 2019;8(1):119–142. doi:https://doi.org/10.1016/j.jcmgh.2019.03.003.
   PubMed Web of Science ®Google Scholar
• Paquet-Fifield S, Koh SL, Cheng L, Beyit LM, Shembrey C, Mølck C, Behrenbruch C, Papin M, Gironella M, Guelfi S, et al. Tight junction protein claudin-2 promotes self-renewal of human colorectal cancer stem-like cells. Cancer Res. 2018;78(11):2925–2938. doi:https://doi.org/10.1158/0008-5472.CAN-17-1869.
   PubMed Web of Science ®Google Scholar